Adaptyv Bio raises €7.2M Seed round
25 September 2025· Lausanne, Switzerland· health, protein_engineering, ai, robotics, b2b, software_hardware
To scale its infrastructure, expand its team, accelerate the development of its end-to-end platform, expand platform capabilities, add new types of assays, enhance automation, and develop an API that connects AI models directly to experimental results.
Investors
LeadACE Ventures
Also participating
byFoundersangel investorsFounderfulLongGame
About Adaptyv Bio
Stage
Seed
Headquarters
Lausanne, Switzerland
Founded
2020
Team Size
21–50
Sectors
healthprotein_engineeringairoboticsb2bsoftware_hardware